Structures by: Nieger M.
Total: 390
3-(2,6-Diisopropylphenyl)-(1,5-a)-pyridine-(1,3,2)- diazaphospholenium-triflate
C18H22N2P,CF3SO3
Dalton Transactions (2008) 36 4937-4945
a=16.983(2)Å b=16.983(2)Å c=16.983(2)Å
α=57.30(1)° β=57.30(1)° γ=57.30(1)°
3-Tert.-butyl-(1,5-a)-pyridine-(1,3,2)-diazaphospholenium- triflate
C10H14N2P,CF3SO3
Dalton Transactions (2008) 36 4937-4945
a=18.492(2)Å b=10.685(1)Å c=15.309(1)Å
α=90.00° β=90.00° γ=90.00°
3-(2,6-Diisopropylphenyl)-(1,5-a)pyridine-2- hexamethyldisilazyl-(1,3,2)-diazaphospholene
C24H40N3PSi2
Dalton Transactions (2008) 36 4937-4945
a=10.2893(3)Å b=10.4169(4)Å c=13.7477(6)Å
α=72.889(2)° β=87.454(2)° γ=71.054(2)°
1,1'-bis(dichlorophosphano)ferrocene
C10H8Cl4FeP2
Dalton transactions (Cambridge, England : 2003) (2006) 32 3879-3885
a=6.7838(1)Å b=11.2938(3)Å c=17.8651(4)Å
α=90.00° β=97.105(2)° γ=90.00°
1,1'-bis(dibromophosphano)ferrocene
C10H8Br4FeP2
Dalton transactions (Cambridge, England : 2003) (2006) 32 3879-3885
a=13.647(4)Å b=8.992(2)Å c=13.668(3)Å
α=90.00° β=119.010(18)° γ=90.00°
Hexa-ter.butyl-tetracyclo(5.5.1.1(3,11).1(5,9))hexasiloxane
C24H54O9Si6
Dalton Transactions (2009) 1 163-167
a=11.935(2)Å b=18.912(4)Å c=16.722(3)Å
α=90.00° β=107.37(2)° γ=90.00°
1,3-Di(tert-butyl)-1,1,3,3-tetrahydroxydisiloxane
C8H22O5Si2
Dalton Transactions (2009) 1 163-167
a=6.222(2)Å b=9.674(3)Å c=11.948(3)Å
α=89.11(3)° β=79.67(3)° γ=81.70(3)°
Hepta-tert.butyl-tricyclo(7.3.3.1(5,11))heptasiloxane-ende- endo-3,7,14-triol
C28H66O12Si7
Dalton Transactions (2009) 1 163-167
a=13.2424(15)Å b=13.2424(15)Å c=90.514(5)Å
α=90.00° β=90.00° γ=120.00°
Tri(tert.butyl)gallium-triethylantimon-adduct
C18H42GaSb
Journal of the Chemical Society, Dalton Transactions (2000) 5 639
a=14.1615(3)Å b=9.5735(2)Å c=16.0291(4)Å
α=90.00° β=90.905(2)° γ=90.00°
Tri(tert.butyl)gallium-tri(isopropyl)antimon-adduct
C21H48GaSb
Journal of the Chemical Society, Dalton Transactions (2000) 5 639
a=13.6128(2)Å b=9.0089(2)Å c=20.0307(2)Å
α=90.00° β=91.750(1)° γ=90.00°
Silver-bis(3-((diphenylphosphanyl)-methyl)-benzene-1,2-diol)- triflate
C38H34AgO4P2CF3SO3CH2Cl2C3H7NO
Dalton transactions (Cambridge, England : 2003) (2007) 35 3906-3913
a=13.818(1)Å b=22.343(2)Å c=15.085(1)Å
α=90.00° β=104.46(1)° γ=90.00°
Silver-bis(4-((diphenylphosphanyl)-methyl)-benzene-1,2-diol)- triflate
[C38H34AgO4P2][CF3SO3],2thf
Dalton transactions (Cambridge, England : 2003) (2007) 35 3906-3913
a=14.3659(3)Å b=16.1257(4)Å c=19.8458(6)Å
α=90.00° β=92.338(1)° γ=90.00°
C44H46BNO4P2
C44H46BNO4P2
Dalton transactions (Cambridge, England : 2003) (2007) 35 3906-3913
a=8.1733(2)Å b=43.2770(10)Å c=11.0401(3)Å
α=90.00° β=94.894(2)° γ=90.00°
C41H37AgBNO5P2
C41H37AgBNO5P2
Dalton transactions (Cambridge, England : 2003) (2007) 35 3906-3913
a=18.8664(8)Å b=15.1936(5)Å c=15.0136(5)Å
α=90.00° β=124.062(2)° γ=90.00°
Triethylammonium Bisd-((diphenylphosphine(benzo-(1,3)-dioxa-4- methyl))-2-borate
C38H30BO4P2Et3NHdme
Dalton transactions (Cambridge, England : 2003) (2007) 35 3906-3913
a=16.3386(2)Å b=16.3500(2)Å c=16.7372(2)Å
α=84.929(1)° β=88.028(1)° γ=89.833(1)°
2-Cyclopentadienyl-1,3-bis-(2,6-diisopropyl-phenyl)-1,3,2- diazaphospholene
C31H41N2Pthf
Dalton Transactions (2007) 19 1891
a=9.9003(2)Å b=18.4544(4)Å c=17.5559(4)Å
α=90.00° β=98.506(1)° γ=90.00°
2-pentamethylcyclopentadienyl-1,3-bis-mesityl-1,3,2- diazaphospholene
C30H39N2P
Dalton Transactions (2007) 19 1891
a=9.9703(2)Å b=10.6255(3)Å c=13.7990(4)Å
α=75.585(1)° β=85.812(1)° γ=69.263(1)°
Dimethoxyethane-lithium-eta$5-2-(1,3-dimesityl-1,3,2- diazaphospholenyl)-cyclopentadienide
(C25H28N2P)Li(C4H10O2)
Dalton Transactions (2007) 19 1891
a=8.5950(3)Å b=21.7213(8)Å c=14.6049(6)Å
α=90.00° β=92.711(2)° γ=90.00°
2-Azido-1,3-bis(2,6-dimethylphenyl)-1,3,2-diazaphospholene
C18H20N5P
Dalton Transactions (2008) 26 3478-3485
a=12.7383(8)Å b=10.8003(8)Å c=12.8025(6)Å
α=90.00° β=90.415(4)° γ=90.00°
1,4,8,11-Tetrakis-(2,6-dimethylphenyl)-1,4,6,8,11,12-hexaaza- 5lambda$5,7lambda5-diphospha-dispiro(4.1.4.1)dodeca-2,9-diene
C36H40N6P2
Dalton Transactions (2008) 26 3478-3485
a=8.3779(3)Å b=17.0975(7)Å c=11.4017(6)Å
α=90.00° β=96.728(2)° γ=90.00°
1,4,8,11-Tetramesityl-1,4,6,8,11,12-hexaaza-5lambda5,7lambda5- diphospha-dispiro(4.1.4.1)-dodeca-2,9-diene
C40H48N6P2benzene
Dalton Transactions (2008) 26 3478-3485
a=22.6662(8)Å b=14.4954(5)Å c=12.2951(4)Å
α=90.00° β=90.00° γ=90.00°
1,4,8,11-Tetramesityl-1,4,6,8,11,12-hexaaza-5,7-diphosphonia- dispiro(4.1.4.1)-dodeca-2,6,9-triene-bis(trifluormethansulfonate)
[C40H50N6P2]22[CF3SO3]2CF3SO3H
Dalton Transactions (2008) 26 3478-3485
a=31.662(2)Å b=12.3344(13)Å c=16.2491(17)Å
α=90.00° β=108.536(3)° γ=90.00°
1,3-Bis-(2,6-diisopropylphenyl)-4,5-dimethyl-2-(1,3-bis-(2,6- diisopropyl-phenyl)-4,5-dimethyl-2-oxo-2lambda5-1,3,2- diazaphospholenylimino)-2lambda5-1,3,2-diazaphospholenylamine
C56H82N6OP2,(C7H8)2
Dalton Transactions (2008) 26 3478-3485
a=13.279(3)Å b=14.542(3)Å c=17.751(4)Å
α=102.26(3)° β=103.09(3)° γ=99.46(3)°
1,3-Bis((perfluoro-tert.butoxy)methyl)-5-iodobenzene
C16H7F18IO2
RSC Adv. (2015)
a=7.2087(4)Å b=11.5510(9)Å c=14.1610(8)Å
α=68.222(5)° β=76.825(5)° γ=73.919(7)°
1-Ethynyl-3,5-bis((perfluorotert.butoxy)methyl)benzene
C18H8F18O2
RSC Adv. (2015)
a=7.0303(4)Å b=11.8119(10)Å c=14.0402(19)Å
α=68.704(8)° β=79.860(6)° γ=74.572(5)°
N-(7-trifluoromethyl)-1H-indazol-3-yl)butyramide
C12H12F3N3O
RSC Adv. (2015)
a=4.8788(4)Å b=10.1605(6)Å c=12.1307(9)Å
α=79.331(5)° β=81.744(7)° γ=86.251(5)°
Ethyl (E)-4-(pyrrolidin-1-yldiazenyl)benzoate
C13H17N3O2
RSC Adv. (2017) 7, 16 9461
a=7.8721(3)Å b=8.4927(3)Å c=10.4598(4)Å
α=68.931(2)° β=89.853(2)° γ=77.388(2)°
Ethyl (E)-4-((2-oxopiperidin-1-yl)diazenyl)benzoate
C14H17N3O3
RSC Adv. (2017) 7, 16 9461
a=14.7907(3)Å b=7.0900(2)Å c=12.8103(3)Å
α=90° β=98.877(1)° γ=90°
Tetrakis(4-(4-phenyl-1,2,3-triazol-1-yl)phenyl)methane
C57H40N12,2(C3H7NO)
Organic & Biomolecular Chemistry (2009) 7, 22 4734-4743
a=29.701(6)Å b=8.996(2)Å c=20.844(4)Å
α=90.00° β=109.53(2)° γ=90.00°
6a,13a-bis(methylthio)hexadecahydropyrazino[1,2-a:4,5-a']diindole-6,13-dione
C20H30N2O2S2
Organic & biomolecular chemistry (2012) 10, 5 935-940
a=9.1262(9)Å b=9.6454(10)Å c=11.5103(9)Å
α=91.426(5)° β=101.320(6)° γ=91.777(5)°
C18H32IN4P
C18H32IN4P
Chemical communications (Cambridge, England) (2018) 54, 55 7645-7648
a=9.4547(6)Å b=19.5345(12)Å c=11.8695(7)Å
α=90° β=94.891(3)° γ=90°
C9H18N2P,I
C9H18N2P,I
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=9.2450(5)Å b=7.4965(4)Å c=10.4442(6)Å
α=90° β=115.069(3)° γ=90°
C28H39N2P
C28H39N2P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17401-17413
a=10.3552(6)Å b=7.0047(4)Å c=37.0995(19)Å
α=90° β=97.948(3)° γ=90°
(2-Bis(trimethylsilyl)methyl-3,5,-di(2-thienyl)-2H-1,4,2- diazaphosphole-kappaP)pentacarbonyltungsten(0)
C22H25N2O5PS2Si2W
New Journal of Chemistry (2010) 34, 8 1593
a=9.5035(3)Å b=10.9580(4)Å c=15.4221(7)Å
α=75.868(2)° β=84.937(2)° γ=65.551(2)°
(5-benzamide-3-(2-methoxyphenyl)-1,2,3-oxadiazol-3-ium-4-yl)triphenylborate
C34H28BN3O3,0.25(C4H10O)
RSC Advances (2019) 9, 9 4781
a=11.2078(4)Å b=16.0505(6)Å c=16.8226(7)Å
α=74.625(2)° β=88.792(2)° γ=85.859(2)°
4-(3,4-dihydro-1H-isoquinolin-2-ylazo)-benzoic acid ethyl ester
C18H19N3O2
RSC Adv. (2017) 7, 16 9461
a=5.9831(5)Å b=33.308(3)Å c=7.7858(7)Å
α=90° β=93.355(2)° γ=90°
C42H35CuN5P2,BF4
C42H35CuN5P2,BF4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=10.889(1)Å b=11.950(1)Å c=16.851(2)Å
α=108.70(1)° β=96.41(1)° γ=107.01(1)°
C84H65Cu2N10O2P4,F6P,2(CH2Cl2)
C84H65Cu2N10O2P4,F6P,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=12.294(1)Å b=13.170(1)Å c=14.471(1)Å
α=71.00(1)° β=85.67(1)° γ=69.54(1)°
C42H32CuN5OP2
C42H32CuN5OP2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=9.0162(4)Å b=17.8097(12)Å c=22.3584(19)Å
α=90.00° β=90.648(6)° γ=90.00°
C48H37CuN3OP2,BF4,0.5(CH2Cl2)
C48H37CuN3OP2,BF4,0.5(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=11.423(1)Å b=14.922(2)Å c=25.552(3)Å
α=90° β=95.86(1)° γ=90°
C43H34CuN4OP2,BF4,0.5(C4H10O)
C43H34CuN4OP2,BF4,0.5(C4H10O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=23.3084(8)Å b=15.1103(8)Å c=23.8529(10)Å
α=90° β=98.530(2)° γ=90°
C112H96Cu4N10P8,2(BF4),2(CH2Cl2)
C112H96Cu4N10P8,2(BF4),2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=15.264(2)Å b=22.970(3)Å c=17.299(3)Å
α=90° β=113.43(1)° γ=90°
C74H62Cu2N6P4,2(F6P),2(C4H10O)
C74H62Cu2N6P4,2(F6P),2(C4H10O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=15.024(1)Å b=14.129(2)Å c=19.206(2)Å
α=90.00° β=108.60(1)° γ=90.00°
C114H98Cu4N8P8,2(BF4)
C114H98Cu4N8P8,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=12.7716(6)Å b=15.7488(7)Å c=28.7966(13)Å
α=87.544(2)° β=80.793(2)° γ=71.984(2)°
C43H36CuN4P2,F6P
C43H36CuN4P2,F6P
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=12.0277(5)Å b=12.9010(5)Å c=14.6324(5)Å
α=100.140(2)° β=113.803(2)° γ=94.065(2)°
C48H39CuN3P2,BF4
C48H39CuN3P2,BF4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 2 608-621
a=11.278(1)Å b=12.684(1)Å c=16.171(1)Å
α=83.52(1)° β=76.41(1)° γ=66.60(1)°
C14H39BClN4PZn
C14H39BClN4PZn
Dalton transactions (Cambridge, England : 2003) (2017) 47, 1 112-119
a=7.7586(8)Å b=29.766(3)Å c=9.2778(8)Å
α=90° β=96.393(4)° γ=90°
C35H59BCuN4P,C4H10O
C35H59BCuN4P,C4H10O
Dalton transactions (Cambridge, England : 2003) (2017) 47, 1 112-119
a=12.4854(9)Å b=16.7096(12)Å c=20.7813(17)Å
α=90° β=90.058(7)° γ=90°
(4-bromophenyl)((1E,5Z)-cycloocta-1,5-dien-1-yl)methanone
C15H15BrO
Dalton transactions (Cambridge, England : 2003) (2018) 47, 11 3689-3692
a=7.2898(3)Å b=11.2179(5)Å c=15.9281(6)Å
α=90° β=100.977(2)° γ=90°
(1-((1E,5Z)-Cycloocta-1,5-dien-1-yl)-2-methylpropanon)platinum(II) chloride
C12H18Cl2OPt
Dalton transactions (Cambridge, England : 2003) (2018) 47, 11 3689-3692
a=15.9169(10)Å b=12.7655(9)Å c=13.2994(10)Å
α=90° β=99.665(2)° γ=90°
C44H76Fe2N4P4Si4,C6H14
C44H76Fe2N4P4Si4,C6H14
Dalton transactions (Cambridge, England : 2003) (2019) 48, 18 6236-6247
a=9.8345(6)Å b=12.3291(7)Å c=12.8154(8)Å
α=107.355(4)° β=102.966(4)° γ=98.309(4)°
C20H30ClFeN2P
C20H30ClFeN2P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 18 6236-6247
a=11.0280(5)Å b=11.9843(6)Å c=16.0493(8)Å
α=90° β=106.938(2)° γ=90°
C16H26BrFeN2PSi2
C16H26BrFeN2PSi2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 18 6236-6247
a=12.0271(8)Å b=11.9819(9)Å c=28.0180(19)Å
α=90° β=90° γ=90°
C20H30Cl4FeN2P2
C20H30Cl4FeN2P2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 18 6236-6247
a=6.1281(6)Å b=11.3691(11)Å c=17.4983(17)Å
α=90° β=97.226(6)° γ=90°
C26H44FeN3P
C26H44FeN3P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 18 6236-6247
a=15.6619(11)Å b=9.3742(6)Å c=18.7966(13)Å
α=90° β=108.622(2)° γ=90°
C40H60Fe2N4P4,C6H14
C40H60Fe2N4P4,C6H14
Dalton transactions (Cambridge, England : 2003) (2019) 48, 18 6236-6247
a=15.3428(7)Å b=17.1185(9)Å c=18.4549(10)Å
α=90° β=93.314(3)° γ=90°
Chloro(perfluorophenyl)(3-(2,2,6,6-tetramethylpiperidin-1-ium-1-yl)- phenyl)hydroborate
C21H24BClF5N
Dalton transactions (Cambridge, England : 2003) (2017) 46, 7 2263-2269
a=10.8901(7)Å b=12.3059(7)Å c=15.2966(10)Å
α=90.00° β=90.00° γ=90.00°
Dichloro(2-(2,2,6,6-tetramethylpiperidin-1-ium-1-yl)phenyl)hydroborate
C15H24BCl2N
Dalton transactions (Cambridge, England : 2003) (2017) 46, 7 2263-2269
a=11.1847(5)Å b=11.3284(5)Å c=12.5977(6)Å
α=90.00° β=90.00° γ=90.00°
Dichloro(perfluorophenyl(2-(2,2,6,6-tetramethylpiperidin-1-ium-1-yl)- phenyl)borate
C21H23BCl2F5N
Dalton transactions (Cambridge, England : 2003) (2017) 46, 7 2263-2269
a=14.123(1)Å b=15.558(1)Å c=19.000(2)Å
α=90.00° β=90.00° γ=90.00°
Trichloro(2-(2,2,6,6-tetramethylpiperidin-1-ium-1-yl)phenyl)borate
C15H23BCl3N
Dalton transactions (Cambridge, England : 2003) (2017) 46, 7 2263-2269
a=7.867(1)Å b=15.592(2)Å c=14.279(2)Å
α=90.00° β=104.89(2)° γ=90.00°
C13H14N4O
C13H14N4O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=12.0896(2)Å b=4.59310(10)Å c=21.5276(5)Å
α=90° β=96.9200(10)° γ=90°
C13H14N4O,C3H4N2,H2O
C13H14N4O,C3H4N2,H2O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=8.4693(4)Å b=13.3280(6)Å c=15.0145(8)Å
α=90° β=103.537(4)° γ=90°
C13H14N4O
C13H14N4O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=7.3327(3)Å b=8.3914(3)Å c=19.4356(9)Å
α=90° β=91.255(2)° γ=90°
Compound 12
C13H14N4O1
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=8.3851(7)Å b=11.5345(6)Å c=12.4214(10)Å
α=90° β=90° γ=90°
C30H52N16O18Pd2
C30H52N16O18Pd2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=13.577(4)Å b=15.891(5)Å c=20.526(6)Å
α=90.00° β=91.995(7)° γ=90.00°
C76H72N8O2P4Pd24,4(CF3SO31)
C76H72N8O2P4Pd24,4(CF3SO31)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=15.7089(3)Å b=16.7004(3)Å c=34.7739(6)Å
α=85.1940(10)° β=82.8360(10)° γ=88.7500(10)°
C80H80N8O2P4Pd24,4(CF3O3S1),3(C3H7NO),1/2(C4H10O),H2O
C80H80N8O2P4Pd24,4(CF3O3S1),3(C3H7NO),1/2(C4H10O),H2O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=16.3896(2)Å b=18.3213(2)Å c=21.5285(3)Å
α=87.680(1)° β=78.927(1)° γ=71.110(1)°
C85.50H81Cl3F12N8O16P4Pd2S4
C85.50H81Cl3F12N8O16P4Pd2S4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 27 8410-8420
a=23.0442(5)Å b=19.7734(4)Å c=25.6540(5)Å
α=90° β=106.8410(10)° γ=90°
1-(2-(bis(perfluorophenyl)boryl)phenyl)-2,2,6,6- tetramethylpiperidin
C27H22BF10N
Dalton transactions (Cambridge, England : 2003) (2012) 41, 30 9029-9032
a=7.8910(5)Å b=17.3435(15)Å c=17.8672(15)Å
α=90.00° β=101.330(7)° γ=90.00°
Bis(perfluorophenyl)(2-(2,2,6,6-tetramethylpiperidin-1-ium- 1yl)phenyl)-hydrobarate
C27H24BF10N,0.5(C6D6)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 30 9029-9032
a=10.944(1)Å b=11.974(1)Å c=12.513(1)Å
α=117.39(1)° β=98.29(1)° γ=106.57(1)°
7,7-dimethyl-8,8-bis(perfluorophenyl)-7-aza-8- borabicyclo(4.2.0)octa-1,3,5-trien-7-ium-8-uide
C20H10BF10N
Dalton transactions (Cambridge, England : 2003) (2012) 41, 30 9029-9032
a=9.8216(4)Å b=35.0210(15)Å c=11.1291(4)Å
α=90.00° β=107.047(2)° γ=90.00°
Bismesitylgallium azide [Mes~2~GaN~3~]~2~
C36H44Ga2N6
Journal of the Chemical Society, Dalton Transactions (1998) 24 4127
a=10.2385(4)Å b=13.6773(4)Å c=14.0356(5)Å
α=69.309(2)° β=74.268(2)° γ=75.279(2)°
[5-Bis(trimethylsilyl)methyl-2,2-dimethyl-4-ferrocenyl-1,3,5- oxazaphosphol-3-ene-kappaP]perntacarbonyltungsten(0)
C26H34FeNO6PSi2W
Dalton transactions (Cambridge, England : 2003) (2010) 39, 47 11445-11450
a=11.7925(1)Å b=12.2414(1)Å c=21.4230(3)Å
α=90.00° β=98.969(1)° γ=90.00°
Joerg142 H.Helten ''HHE-DR05'' 100K 13.02.08
C26H34FeN3O5PSi2W
Dalton transactions (Cambridge, England : 2003) (2010) 39, 47 11445-11450
a=16.0145(5)Å b=12.3033(4)Å c=16.1955(3)Å
α=90.00° β=103.387(2)° γ=90.00°
[5-Bis(trimethylsilyl)methyl-2,4-bisferrocenyl-1,3,5- oxazaphosphol-3-ene-kappaP]pentacarbonyltungsten(0)
C34H38Fe2NO6PSi2W
Dalton transactions (Cambridge, England : 2003) (2010) 39, 47 11445-11450
a=18.8898(2)Å b=28.5021(3)Å c=13.8338(1)Å
α=90.00° β=90.00° γ=90.00°
2-(1,3-bis(2,6-diisopropylphenyl)-1,3,2-diazaborolen-2-yl)- 1,3-di-tert-butyl-1,3,2-diazaphospholene
C36H56BN4P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=11.7029(8)Å b=12.3599(8)Å c=24.3641(18)Å
α=90.00° β=96.785(3)° γ=90.00°
2-(1,3-bis(2,6-diisopropylphenyl)-1,3,2-diazaborolen-2-yl)- 1,3-bis(2,6-dimethylphenyl)-1,3,2-diazaphospholene
C44H56BN4P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=12.4257(4)Å b=12.4802(5)Å c=13.2635(5)Å
α=97.682(2)° β=98.396(2)° γ=103.761(2)°
1,3-bis(2,6-diisopropylphenyl)-2-(phenylphosphanyl)-1,3,2-diazaborolene
C32H42BN2P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=12.0947(13)Å b=13.6131(12)Å c=17.9876(14)Å
α=90.00° β=90.00° γ=90.00°
1,3-bis(2,6-diisopropylphenyl)-2-phosphanyl-1,3,2-diazaborolene
C26H38BN2P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 2 680-689
a=7.5063(5)Å b=9.4119(6)Å c=18.3880(14)Å
α=77.441(3)° β=86.774(4)° γ=78.004(3)°
(S,S)-2-(3'-(1-Methoxycarbonyl-ethylcarbamoyl)-(4,4')- bipyridinyl-3-carbonyl)-amino-propionic acid methyl ester
C20H22N4O6
Chemical communications (Cambridge, England) (2008) 39 4789-4791
a=8.709(1)Å b=11.104(1)Å c=21.032(3)Å
α=90.00° β=90.00° γ=90.00°
(R,R)-2-(3'-(1-Methoxycarbonyl-ethylcarbamoyl)-(4,4')- bipyridinyl-3-carbonyl)-amino-propionic acid methyl ester
C20H22N4O6
Chemical communications (Cambridge, England) (2008) 39 4789-4791
a=8.732(1)Å b=11.123(1)Å c=21.076(2)Å
α=90.00° β=90.00° γ=90.00°
C188H192N16O24P8Pt4,8(CF3O3S),7(C3H6O)
C188H192N16O24P8Pt4,8(CF3O3S),7(C3H6O)
Chemical communications (Cambridge, England) (2008) 39 4789-4791
a=14.955(1)Å b=27.472(1)Å c=31.536(3)Å
α=90.00° β=100.57(1)° γ=90.00°
C42H34CuN5P2
C42H34CuN5P2
Chem.Commun. (2013) 49, 6501
a=9.0816(2)Å b=18.2546(6)Å c=22.2364(6)Å
α=90.00° β=91.356(2)° γ=90.00°
C42H35CuN5P2,BF4
C42H35CuN5P2,BF4
Chem.Commun. (2013) 49, 6501
a=10.889(1)Å b=11.950(1)Å c=16.851(2)Å
α=108.70(1)° β=96.41(1)° γ=107.01(1)°
C42H32CuN5OP2
C42H32CuN5OP2
Chem.Commun. (2013) 49, 6501
a=9.0162(4)Å b=17.8097(12)Å c=22.3584(19)Å
α=90.00° β=90.648(6)° γ=90.00°
C84H65Cu2N10O2P4,F6P,2(CH2Cl2)
C84H65Cu2N10O2P4,F6P,2(CH2Cl2)
Chem.Commun. (2013) 49, 6501
a=12.294(1)Å b=13.170(1)Å c=14.471(1)Å
α=71.00(1)° β=85.67(1)° γ=69.54(1)°
C45H36CuN5OP2
C45H36CuN5OP2
Chem.Commun. (2013) 49, 6501
a=10.0720(6)Å b=20.3844(18)Å c=17.9511(18)Å
α=90.00° β=94.184(5)° γ=90.00°
C44H36CuN5OP2
C44H36CuN5OP2
Chem.Commun. (2013) 49, 6501
a=9.3177(7)Å b=18.3378(9)Å c=22.3498(18)Å
α=90.00° β=90.654(7)° γ=90.00°
C21H19NO3S
C21H19NO3S
Chemical Communications (2005)
a=12.6115(1)Å b=5.9741(1)Å c=24.2313(2)Å
α=90.00° β=101.681(1)° γ=90.00°
(Z)-ethyl 2-(6-(tert.butyldimethylsiloxyl)benzo(d)(1,3)dioxol- 5-yl)-2-(diphenylphosphorylimino)acetate
C29H34NO6PSi
Chem.Commun. (2010) 46, 9215
a=10.199(1)Å b=16.574(2)Å c=17.054(2)Å
α=90.00° β=90.00° γ=90.00°
(Z)-ethyl-2-(diphenylphosphorylimino)-2-(6- hydroxybenzo(d)(1,3)dioxol-5-yl)acetate
C23H20NO6P
Chem.Commun. (2010) 46, 9215
a=8.475(1)Å b=11.476(1)Å c=11.734(1)Å
α=103.66(1)° β=107.51(1)° γ=94.34(1)°
N-(7-methyl-6-oxo-6,7-dihydro-(1,3)dioxolo(4,5-f)benzofuran-7- yl)-P,P-diphenylphosphinic amide
C22H18NO5P
Chem.Commun. (2010) 46, 9215
a=5.894(1)Å b=10.203(2)Å c=16.399(3)Å
α=97.76(2)° β=96.88(2)° γ=99.17(2)°
N-(7-methyl-6-oxo-6,7-dihydro-(1,3)-dioxolo(4,5-f)benzofuran- 7-yl)-P,P'diphenylphosphinic amide
C22H18NO5P,0.25(C3H8O)
Chem.Commun. (2010) 46, 9215
a=10.237(1)Å b=16.524(1)Å c=23.793(2)Å
α=96.01(1)° β=100.12(1)° γ=97.69(1)°
N-(5-(allyloxy)-6-hydroxy-3-methyl-2-oxo-2,3- dihydrobenzofuran-3-yl)-P,P-diphenylphosphinic amide
C24H22NO5P
Chem.Commun. (2010) 46, 9215
a=10.509(1)Å b=13.334(1)Å c=16.224(1)Å
α=83.82(1)° β=79.60(1)° γ=75.14(1)°
1-(4-Amino-5,6-dichloro-pyrimidin-2-yl)-4-(pyridin-4-yl)- pyridinium chloride
(C14H10Cl2N5)(Cl)2H2O
Journal of the Chemical Society, Perkin Transactions 1 (1999) 10 1325
a=7.8039(3)Å b=16.9741(4)Å c=12.6159(6)Å
α=90.00° β=99.222(2)° γ=90.00°
14,17-Dimethyl-[2](1,3)azuleno[2]paracyclophane
C22H22
Journal of the Chemical Society, Perkin Transactions 2 (1999) 3 521
a=7.9870(2)Å b=12.6805(4)Å c=8.1337(3)Å
α=90.00° β=105.788(2)° γ=90.00°
1,3-bis-(2,6-diisopropylphenyl)-1,3,2-diazaphospholenium-tricarbonyl-ferrate(-II)
C29H37FeN2O3P
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6023-6031
a=10.9098(8)Å b=15.3843(11)Å c=17.7380(11)Å
α=90.00° β=99.998(2)° γ=90.00°
Bis(1,3-bis(2,6-diisopropylphenyl)-1,3,2-diazaphospholenium)-dicarbonyl-ferrate(-II)
C54H72FeN4O2P2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6023-6031
a=13.5063(5)Å b=21.9821(8)Å c=18.0479(5)Å
α=90.00° β=107.7750(10)° γ=90.00°
(2-methyl-1,3-bis(2,6-diisopropylphenyl)-1,3,2-diazaphospholene)-tetracarbonyl-iron(0)
C31H39FeN2O4P
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6023-6031
a=19.7315(14)Å b=20.5098(16)Å c=7.4442(6)Å
α=90.00° β=90.00° γ=90.00°
{1,3-bis-(2,6-diisopropylphenyl)-1,3,2-diazaphospholenium}-triphenyl-stannyl-tricarbonyl ferrate(II)
C47H51FeN2O3PSn
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6023-6031
a=11.5843(6)Å b=12.2340(6)Å c=17.8887(11)Å
α=92.606(3)° β=103.175(3)° γ=116.117(2)°